Imminent FDA Approval of Addictive Ketamine for Depression Brings Back Echoes from the Opiate Epidemic P&T CommunityWEST ORANGE, N.J., March 4, 2019 /PRNewswire/ -- FDA's approval of ketamine to address depression classified as 'treatment resistant' is a double-edged ...